Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F PRESCOTT

Showing results (341-350 of 383) with videos related to

Pageof 39
Sort By:
JACC. Heart Failure|February 4, 2022
Early B-Type Natriuretic Peptide Change in HFrEF Patients Treated With Sacubitril/Valsartan: A Pooled Analysis of EVALUATE-HF and PROVE-HFPeder L Myhre, Margaret F Prescott, Sean P Murphy, et al.
European Journal of Heart Failure|September 18, 2020
Sex-based differences in biomarkers, health status, and reverse cardiac remodelling in patients with heart failure with reduced ejection fraction treated with sacubitril/valsartanNasrien E Ibrahim, Ileana L Piña, Alexander Camacho, et al.
Circulation. Heart Failure|October 5, 2020
Racial and Ethnic Differences in Biomarkers, Health Status, and Cardiac Remodeling in Patients With Heart Failure With Reduced Ejection Fraction Treated With Sacubitril/ValsartanNasrien E Ibrahim, Ileana L Piña, Alexander Camacho, et al.
Infection and Immunity|November 18, 2000
DNA sequence and comparison of virulence plasmids from Rhodococcus equi ATCC 33701 and 103S Takai, S A Hines, T Sekizaki, et al.
European Journal of Heart Failure|January 20, 2015
Clinical profile and prognostic significance of natriuretic peptide trajectory following hospitalization for worsening chronic heart failure: findings from the ASTRONAUT trialStephen J Greene, Aldo P Maggioni, Gregg C Fonarow, et al.
Circulation. Heart Failure|January 13, 2016
Plasma Biomarkers Reflecting Profibrotic Processes in Heart Failure With a Preserved Ejection Fraction: Data From the Prospective Comparison of ARNI With ARB on Management of Heart Failure With Preserved Ejection Fraction StudyMichael R Zile, Pardeep S Jhund, Catalin F Baicu, et al.
European Journal of Heart Failure|April 5, 2011
Associations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment studyColette E Jackson, Michael R MacDonald, Mark C Petrie, et al.
Hypertension (Dallas, Tex. : 1979)|November 17, 2016
Effects of Sacubitril/Valsartan (LCZ696) on Natriuresis, Diuresis, Blood Pressures, and NT-proBNP in Salt-Sensitive HypertensionTzung-Dau Wang, Ru-San Tan, Hae-Young Lee, et al.
Journal of the American College of Cardiology|December 3, 2016
Prognostic Implications of Changes in N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Heart FailureMichael R Zile, Brian L Claggett, Margaret F Prescott, et al.
Clinical Chemistry|September 14, 2022
Comparative Effect of Angiotensin Receptor Neprilysin Inhibition on B-type Natriuretic Peptide Levels Measured by Three Different Assays: The PROVE-HF StudyPeder L Myhre, Margaret F Prescott, Brian Claggett, et al.
Pageof 39

Showing results (341-350 of 383) with videos related to

Sort By:
Pageof 39
JACC. Heart Failure|February 4, 2022
Early B-Type Natriuretic Peptide Change in HFrEF Patients Treated With Sacubitril/Valsartan: A Pooled Analysis of EVALUATE-HF and PROVE-HFPeder L Myhre, Margaret F Prescott, Sean P Murphy, et al.
European Journal of Heart Failure|September 18, 2020
Sex-based differences in biomarkers, health status, and reverse cardiac remodelling in patients with heart failure with reduced ejection fraction treated with sacubitril/valsartanNasrien E Ibrahim, Ileana L Piña, Alexander Camacho, et al.
Circulation. Heart Failure|October 5, 2020
Racial and Ethnic Differences in Biomarkers, Health Status, and Cardiac Remodeling in Patients With Heart Failure With Reduced Ejection Fraction Treated With Sacubitril/ValsartanNasrien E Ibrahim, Ileana L Piña, Alexander Camacho, et al.
Infection and Immunity|November 18, 2000
DNA sequence and comparison of virulence plasmids from Rhodococcus equi ATCC 33701 and 103S Takai, S A Hines, T Sekizaki, et al.
European Journal of Heart Failure|January 20, 2015
Clinical profile and prognostic significance of natriuretic peptide trajectory following hospitalization for worsening chronic heart failure: findings from the ASTRONAUT trialStephen J Greene, Aldo P Maggioni, Gregg C Fonarow, et al.
Circulation. Heart Failure|January 13, 2016
Plasma Biomarkers Reflecting Profibrotic Processes in Heart Failure With a Preserved Ejection Fraction: Data From the Prospective Comparison of ARNI With ARB on Management of Heart Failure With Preserved Ejection Fraction StudyMichael R Zile, Pardeep S Jhund, Catalin F Baicu, et al.
European Journal of Heart Failure|April 5, 2011
Associations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment studyColette E Jackson, Michael R MacDonald, Mark C Petrie, et al.
Hypertension (Dallas, Tex. : 1979)|November 17, 2016
Effects of Sacubitril/Valsartan (LCZ696) on Natriuresis, Diuresis, Blood Pressures, and NT-proBNP in Salt-Sensitive HypertensionTzung-Dau Wang, Ru-San Tan, Hae-Young Lee, et al.
Journal of the American College of Cardiology|December 3, 2016
Prognostic Implications of Changes in N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Heart FailureMichael R Zile, Brian L Claggett, Margaret F Prescott, et al.
Clinical Chemistry|September 14, 2022
Comparative Effect of Angiotensin Receptor Neprilysin Inhibition on B-type Natriuretic Peptide Levels Measured by Three Different Assays: The PROVE-HF StudyPeder L Myhre, Margaret F Prescott, Brian Claggett, et al.
Pageof 39